Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Disease Progression and IGHV[original query]
Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.
Leukemia research 2015 Aug 39 (8): 840-5.
Morabito Fortunato, Cutrona Giovanna, Mosca Laura, D'Anca Marianna, Matis Serena, Gentile Massimo, Vigna Ernesto, Colombo Monica, Recchia Anna Grazia, Bossio Sabrina, De Stefano Laura, Maura Francesco, Manzoni Martina, Ilariucci Fiorella, Consoli Ugo, Vincelli Iolanda, Musolino Caterina, Cortelezzi Agostino, Molica Stefano, Ferrarini Manlio, Neri Antoni
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia.
Leukemia 2017 1 31 (6): 1348-1354.
Murphy E J, Neuberg D S, Rassenti L Z, Hayes G, Redd R, Emson C, Li K, Brown J R, Wierda W G, Turner S, Greaves A W, Zent C S, Byrd J C, McConnel C, Barrientos J, Kay N, Hellerstein M K, Chiorazzi N, Kipps T J, Rai K
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.
The New England journal of medicine 2019 8 381 (5): 432-443.
Shanafelt Tait D, Wang Xin V, Kay Neil E, Hanson Curtis A, O'Brien Susan, Barrientos Jacqueline, Jelinek Diane F, Braggio Esteban, Leis Jose F, Zhang Cong C, Coutre Steven E, Barr Paul M, Cashen Amanda F, Mato Anthony R, Singh Avina K, Mullane Michael P, Little Richard F, Erba Harry, Stone Richard M, Litzow Mark, Tallman Mart
Activation of hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia.
Blood 2019 3 133 (25): 2651-2663.
Ghia Emanuela M, Rassenti Laura Z, Neuberg Donna S, Blanco Alejandro, Yousif Fouad, Smith Erin N, McPherson John D, Hudson Thomas J, , Harismendy Olivier, Frazer Kelly A, Kipps Thomas
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.
Scientific reports 2020 10 10 (1): 18427.
Monti Paola, Lionetti Marta, De Luca Giuseppa, Menichini Paola, Recchia Anna Grazia, Matis Serena, Colombo Monica, Fabris Sonia, Speciale Andrea, Barbieri Marzia, Gentile Massimo, Zupo Simonetta, Dono Mariella, Ibatici Adalberto, Neri Antonino, Ferrarini Manlio, Fais Franco, Fronza Gilberto, Cutrona Giovanna, Morabito Fortuna
The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome.
Frontiers in oncology 2021 11 723722.
Rodríguez-Caballero Arancha, Fuentes Herrero Blanca, Oliva Ariza Guillermo, Criado Ignacio, Alcoceba Miguel, Prieto Carlos, Pérez Caro María, García-Montero Andrés C, González Díaz Marcos, Forconi Francesco, Sarmento-Ribeiro Ana Bela, Almeida Julia, Orfao Alber
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants.
Annals of hematology 2024 5 .
María Belén Fontecha, María Del Rosario Anadón, Verónica Mercado Guzmán, Carmen Stanganelli, Camila Galvano, Fernanda Tosin, Javier Bordone, Raimundo Bezares, Cecilia Rodríguez, Viviana Heller, Irma Slavutsky, Ariela Freya Fund
TOP